149 related articles for article (PubMed ID: 1754507)
1. Paragangliomas of the head and neck. Immunohistochemical analysis of 16 cases in comparison with neuro-endocrine carcinomas.
Martinez-Madrigal F; Bosq J; Micheau C; Nivet P; Luboinski B
Pathol Res Pract; 1991 Sep; 187(7):814-23. PubMed ID: 1754507
[TBL] [Abstract][Full Text] [Related]
2. A comparative immunohistochemical study of phaeochromocytomas and paragangliomas.
Fraga M; García-Caballero T; Antúnez J; Couce M; Beiras A; Forteza J
Histol Histopathol; 1993 Jul; 8(3):429-36. PubMed ID: 8358154
[TBL] [Abstract][Full Text] [Related]
3. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing.
Johnson TL; Zarbo RJ; Lloyd RV; Crissman JD
Mod Pathol; 1988 May; 1(3):216-23. PubMed ID: 2467285
[TBL] [Abstract][Full Text] [Related]
4. Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques.
Kliewer KE; Wen DR; Cancilla PA; Cochran AJ
Hum Pathol; 1989 Jan; 20(1):29-39. PubMed ID: 2912871
[TBL] [Abstract][Full Text] [Related]
5. Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results.
Castelblanco E; Gallel P; Ros S; Gatius S; Valls J; De-Cubas AA; Maliszewska A; Yebra-Pimentel MT; Menarguez J; Gamallo C; Opocher G; Robledo M; Matias-Guiu X
Hum Pathol; 2012 Jul; 43(7):1103-12. PubMed ID: 22209341
[TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism.
Douwes Dekker PB; Kuipers-Dijkshoorn NJ; Baelde HJ; van der Mey AG; Hogendoorn PC; Cornelisse CJ
Hum Pathol; 2007 Jan; 38(1):79-85. PubMed ID: 16949906
[TBL] [Abstract][Full Text] [Related]
7. [Histological characteristics of head and neck paragangliomas].
Antúnez Plaza P; Santos-Briz Terrón A; Sáncho de Salas M; Flores Corral T
Acta Otorrinolaringol Esp; 2009 Feb; 60 Suppl 1():18-23. PubMed ID: 19245771
[TBL] [Abstract][Full Text] [Related]
8. [Galanin immunoreactivity in a laryngeal paraganglioma: case report and literature review].
Squillaci S; Gal AA
Pathologica; 2004 Jun; 96(3):111-6. PubMed ID: 15524051
[TBL] [Abstract][Full Text] [Related]
9. Galanin immunoreactivity in neuroendocrine tumors.
Sano T; Vrontakis ME; Kovacs K; Asa SL; Friesen HG
Arch Pathol Lab Med; 1991 Sep; 115(9):926-9. PubMed ID: 1718239
[TBL] [Abstract][Full Text] [Related]
10. Stathmin expression in pheochromocytomas, paragangliomas, and in other endocrine tumors.
Sadow PM; Rumilla KM; Erickson LA; Lloyd RV
Endocr Pathol; 2008; 19(2):97-103. PubMed ID: 18461287
[TBL] [Abstract][Full Text] [Related]
11. Paragangliomas of the head and neck region. A pathologic study of tumors from 71 patients.
Lack EE; Cubilla AL; Woodruff JM
Hum Pathol; 1979 Mar; 10(2):191-218. PubMed ID: 422190
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
13. Cytokeratins expression in paragangliomas of the cauda equina.
Labrousse F; Leboutet MJ; Petit B; Paraf F; Boncoeur-Martel MP; Moreau JJ; Catanzano G
Clin Neuropathol; 1999; 18(4):208-13. PubMed ID: 10442464
[TBL] [Abstract][Full Text] [Related]
14. [Head and neck paraganglioma--neoplasm of nervous origin].
Dorobisz AT; Zaleska P
Pol Merkur Lekarski; 2004 Sep; 17(99):292-6. PubMed ID: 15628063
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine carcinomas of the larynx. A study of two types, one of which mimics thyroid medullary carcinoma.
Woodruff JM; Huvos AG; Erlandson RA; Shah JP; Gerold FP
Am J Surg Pathol; 1985 Nov; 9(11):771-90. PubMed ID: 2866724
[TBL] [Abstract][Full Text] [Related]
16. [Paragangliomas of the head and neck. Our experience].
Alvarez Zapico MJ; Llorente Pendás JL; Suárez Nieto C; Carreño Villarreal M; Moro Melón M
Acta Otorrinolaringol Esp; 1998 Apr; 49(3):177-82. PubMed ID: 9644854
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistologic findings in paragangliomas in the area of the head and neck].
Milewski C; Dienes HP; Collo D
Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):385-8. PubMed ID: 3062287
[TBL] [Abstract][Full Text] [Related]
18. A comparison of paraganglioma, carcinoid tumor, and small-cell carcinoma of the larynx.
Googe PB; Ferry JA; Bhan AK; Dickersin GR; Pilch BZ; Goodman M
Arch Pathol Lab Med; 1988 Aug; 112(8):809-15. PubMed ID: 2840051
[TBL] [Abstract][Full Text] [Related]
19. Thyroid-associated paragangliomas.
Phitayakorn R; Faquin W; Wei N; Barbesino G; Stephen AE
Thyroid; 2011 Jul; 21(7):725-33. PubMed ID: 21615305
[TBL] [Abstract][Full Text] [Related]
20. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck.
Serrano MF; El-Mofty SK; Gnepp DR; Lewis JS
Hum Pathol; 2008 Apr; 39(4):591-8. PubMed ID: 18284937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
